Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.

Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Resúmenes publicados
Búsqueda
Corea y enfermedad de Huntington Chorea & Huntington’s disease 162 artículos Viendo del 1 al 40 de 162 artículos
Pub MED

What is gained or 'lost in translation' in Huntington's disease.NUEVO

Brouillet E, Merienne K.
Brain. 2019 Oct 1;142(10):2900-2902. doi: 10.1093/brain/awz274. No abstract available.
Pub MED

Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease.NUEVO

Paulsen JS, Coffey CS.
Lancet Neurol. 2019 Oct;18(10):911-912. doi: 10.1016/S1474-4422(19)30329-1. No abstract available.
Pub MED

Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.NUEVO

Radovanović S, Vodopić S, Stanković I, Dragašević-Mišković N, Kostić V.
Int J Neurosci. 2019 Oct 2:1-8. doi: 10.1080/00207454.2019.1667781. [Epub ahead of print]
Pub MED

Self-organizing neuruloids model developmental aspects of Huntington's disease in the ectodermal compartment.NUEVO

Haremaki T, Metzger JJ, Rito T, Ozair MZ, Etoc F, Brivanlou AH.
Nat Biotechnol. 2019 Oct;37(10):1198-1208. doi: 10.1038/s41587-019-0237-5. Epub 2019 Sep 9.
Pub MED

Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory.NUEVO

Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL.
Cortex. 2019 Oct;119:417-427. doi: 10.1016/j.cortex.2019.07.014. Epub 2019 Aug 13.
Pub MED

Increased translation as a novel pathogenic mechanism in Huntington's disease.NUEVO

Creus-Muncunill J, Badillos-Rodríguez R, Garcia-Forn M, Masana M, Garcia-Díaz Barriga G, Guisado-Corcoll A, Alberch J, Malagelada C, Delgado-García JM, Gruart A, Pérez-Navarro E.
Brain. 2019 Oct 1;142(10):3158-3175. doi: 10.1093/brain/awz230.
Pub MED

Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.NUEVO

Zhang Y, Ren R, Yang L, Zhou J, Li Y, Shi J, Lu L, Sanford LD, Tang X.
Sleep. 2019 Oct 9;42(10). pii: zsz154. doi: 10.1093/sleep/zsz154.
Pub MED

Quality Control in Huntington's Disease: a Therapeutic Target.NUEVO

Rai SN, Singh BK, Rathore AS, Zahra W, Keswani C, Birla H, Singh SS, Dilnashin H, Singh SP.
Neurotox Res. 2019 Oct;36(3):612-626. doi: 10.1007/s12640-019-00087-x. Epub 2019 Jul 11. Review.
Pub MED

Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.NUEVO

Hirano M, Iritani S, Fujishiro H, Torii Y, Habuchi C, Sekiguchi H, Yoshida M, Ozaki N.
Neuropathology. 2019 Oct;39(5):331-341. doi: 10.1111/neup.12578. Epub 2019 Jul 2.
Pub MED

Network spread determines severity of degeneration and disconnection in Huntington's disease.NUEVO

Poudel GR, Harding IH, Egan GF, Georgiou-Karistianis N.
Hum Brain Mapp. 2019 Oct 1;40(14):4192-4201. doi: 10.1002/hbm.24695. Epub 2019 Jun 12.
Pub MED

Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.NUEVO

Imbert M, Blandel F, Leumann C, Garcia L, Goyenvalle A.
Nucleic Acid Ther. 2019 Oct;29(5):256-265. doi: 10.1089/nat.2018.0775. Epub 2019 Jun 11.
Pub MED

Emerging therapies in Huntington's disease.NUEVO

Bashir H.
Expert Rev Neurother. 2019 Oct;19(10):983-995. doi: 10.1080/14737175.2019.1631161. Epub 2019 Jun 17.
Pub MED

Can leukocyte telomere shortening be a possible biomarker to track Huntington's disease progression?NUEVO

Mantuano E, Peconi M, Scarabino D.
Neural Regen Res. 2019 Oct;14(10):1709-1710. doi: 10.4103/1673-5374.257522. No abstract available.
Pub MED

'Real-life' hippocampal-dependent spatial memory impairments in Huntington's disease.NUEVO

Glikmann-Johnston Y, Carmichael AM, Mercieca EC, Stout JC.
Cortex. 2019 Oct;119:46-60. doi: 10.1016/j.cortex.2019.04.006. Epub 2019 Apr 15.
Pub MED

Impaired Remyelination in a Mouse Model of Huntington Disease.NUEVO

Teo RTY, Ferrari Bardile C, Tay YL, Yusof NABM, Kreidy CA, Tan LJ, Pouladi MA.
Mol Neurobiol. 2019 Oct;56(10):6873-6882. doi: 10.1007/s12035-019-1579-1. Epub 2019 Apr 2.
Pub MED

Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice.NUEVO

Park H, Miyazaki H, Yamanaka T, Nukina N.
Neurosci Res. 2019 Oct;147:58-63. doi: 10.1016/j.neures.2018.10.013. Epub 2018 Nov 2.
Pub MED

Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration.NUEVO

Sava V, Fihurka O, Khvorova A, Sanchez-Ramos J.
Nanomedicine. 2019 Oct 27:102119. doi: 10.1016/j.nano.2019.102119. [Epub ahead of print]
Pub MED

Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study.NUEVO

Bartlett DM, Dominguez D JF, Lazar AS, Kordsachia CC, Rankin TJ, Lo J, Govus AD, Power BD, Lampit A, Eastwood PR, Ziman MR, Cruickshank TM.
J Neurol Sci. 2019 Oct 13;408:116522. doi: 10.1016/j.jns.2019.116522. [Epub ahead of print]
Pub MED

Motor speech patterns in Huntington disease.NUEVO

Diehl SK, S Mefferd A, Lin YC, Sellers J, E McDonell K, de Riesthal M, Claassen DO.
Neurology. 2019 Oct 29. pii: 10.1212/WNL.0000000000008541. doi: 10.1212/WNL.0000000000008541. [Epub ahead of print]
Pub MED

Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.NUEVO

Ringkøbing SP, Larsen IU, Jørgensen K, Vinther-Jensen T, Vogel A.
J Huntingtons Dis. 2019 Oct 21. doi: 10.3233/JHD-190350. [Epub ahead of print]
Pub MED

Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration.NUEVO

Ardan T, Baxa M, Levinská B, Sedláčková M, Nguyen TD, Klíma J, Juhás Š, Juhásová J, Šmatlíková P, Vochozková P, Motlík J, Ellederová Z.
Dis Model Mech. 2019 Oct 23. pii: dmm.041319. doi: 10.1242/dmm.041319. [Epub ahead of print]
Pub MED

Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.NUEVO

Carbo M, Brandi V, Pascarella G, Staid DS, Colotti G, Polticelli F, Ilari A, Morea V.
Int J Mol Med. 2019 Oct 15. doi: 10.3892/ijmm.2019.4373. [Epub ahead of print]
Pub MED

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's disease.NUEVO

Elifani F, Amico E, Pepe G, Capocci L, Castaldo S, Rosa P, Montano E, Pollice A, Madonna M, Filosa S, Calogero A, Maglione V, Crispi S, Di Pardo A.
Hum Mol Genet. 2019 Oct 20. pii: ddz247. doi: 10.1093/hmg/ddz247. [Epub ahead of print]
Pub MED

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.NUEVO

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E.
Metab Brain Dis. 2019 Oct 17. doi: 10.1007/s11011-019-00500-6. [Epub ahead of print] Review.
Pub MED

Astrocyte molecular signatures in Huntington's disease.NUEVO

Diaz-Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS.
Sci Transl Med. 2019 Oct 16;11(514). pii: eaaw8546. doi: 10.1126/scitranslmed.aaw8546.
Pub MED

The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain.NUEVO

Agus F, Crespo D, Myers RH, Labadorf A.
BMC Med Genomics. 2019 Oct 16;12(1):137. doi: 10.1186/s12920-019-0581-9.
Pub MED

A Combinatorial Cell and Drug Delivery Strategy for Huntington's Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells.NUEVO

André EM, Delcroix GJ, Kandalam S, Sindji L, Montero-Menei CN.
Pharmaceutics. 2019 Oct 12;11(10). pii: E526. doi: 10.3390/pharmaceutics11100526.
Pub MED

Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt(Q140/Q140) mouse model of Huntington's disease.NUEVO

McAdam RL, Morton A, Gordon SL, Alterman JF, Khvorova A, Cousin MA, Smillie KJ.
Neurobiol Dis. 2019 Oct 12;134:104637. doi: 10.1016/j.nbd.2019.104637. [Epub ahead of print]
Pub MED

Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.NUEVO

Claassen DO, Philbin M, Carroll B.
Expert Opin Pharmacother. 2019 Oct 15:1-13. doi: 10.1080/14656566.2019.1674281. [Epub ahead of print]
Pub MED

Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study.NUEVO

Connors MH, Teixeira-Pinto A, Loy CT.
J Neurol Neurosurg Psychiatry. 2019 Oct 13. pii: jnnp-2019-320646. doi: 10.1136/jnnp-2019-320646. [Epub ahead of print]
Pub MED

How different aspects of motor dysfunction influence day-to-day function in huntington's disease.NUEVO

Carlozzi NE, Schilling SG, Boileau NR, Chou KL, Perlmutter JS, Frank S, McCormack MK, Stout JC, Paulsen JS, Lai JS, Dayalu P.
Mov Disord. 2019 Oct 14. doi: 10.1002/mds.27866. [Epub ahead of print]
Pub MED

A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.NUEVO

Ciosi M, Maxwell A, Cumming SA, Hensman Moss DJ, Alshammari AM, Flower MD, Durr A, Leavitt BR, Roos RAC; TRACK-HD team.; Enroll-HD team., Holmans P, Jones L, Langbehn DR, Kwak S, Tabrizi SJ, Monckton DG.
EBioMedicine. 2019 Oct 4. pii: S2352-3964(19)30624-3. doi: 10.1016/j.ebiom.2019.09.020. [Epub ahead of print]
Pub MED

Acute manganese treatment restores defective autophagic cargo loading in Huntington's Disease cell lines.NUEVO

Bryan MR, O'Brien MT, Nordham KD, Rose DIR, Foshage AM, Joshi P, Nitin R, Uhouse MA, Di Pardo A, Zhang Z, Maglione V, Aschner M, Bowman AB.
Hum Mol Genet. 2019 Oct 10. pii: ddz209. doi: 10.1093/hmg/ddz209. [Epub ahead of print]
Pub MED

Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease.NUEVO

Mori S, Honda H, Ishii T, Yoshimura M, Sasagasako N, Suzuki SO, Taniwaki T, Iwaki T.
Neuropathology. 2019 Oct;39(5):358-367. doi: 10.1111/neup.12600. Epub 2019 Oct 9.
Pub MED

Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.NUEVO

Li HL, Li XY, Dong Y, Zhang YB, Cheng HR, Gan SR, Liu ZJ, Ni W, Burgunder JM, Yang XW, Wu ZY.
Aging Dis. 2019 Oct 1;10(5):1003-1011. doi: 10.14336/AD.2018.0911. eCollection 2019 Oct.
Pub MED

An exploration of physical activity experiences throughout the Huntington's disease journey: supporting development of theoretically underpinned complex interventions.NUEVO

Hamana K, Quinn L, Gambling T, Busse M.
Disabil Rehabil. 2019 Oct 7:1-11. doi: 10.1080/09638288.2019.1671501. [Epub ahead of print]
Pub MED

Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease.NUEVO

Norrbacka S, Lindholm D, Myöhänen TT.
J Cell Mol Med. 2019 Sep 29. doi: 10.1111/jcmm.14675. [Epub ahead of print] No abstract available.
Pub MED

A Deep Learning-Based Approach for Gait Analysis in Huntington Disease.

Zhang S, Poon SK, Vuong K, Sneddon A, Loy CT.
Stud Health Technol Inform. 2019 Aug 21;264:477-481. doi: 10.3233/SHTI190267.
Pub MED

Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms.

Ramond F, Quadrio I, Le Vavasseur L, Chaumet H, Boyer F, Bost M, Ollagnon-Roman E.
Mol Genet Genomic Med. 2019 Aug 22:e881. doi: 10.1002/mgg3.881. [Epub ahead of print]
Pub MED

Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Carlozzi NE, Goodnight S, Kratz AL, Stout JC, McCormack MK, Paulsen JS, Boileau NR, Cella D, Ready RE.
J Huntingtons Dis. 2019 Aug 16. doi: 10.3233/JHD-190364. [Epub ahead of print]
Viendo del 1 al 40 de 162 artículos
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy